| First Author | Lovitch SB | Year | 2007 |
| Journal | J Immunol | Volume | 178 |
| Issue | 1 | Pages | 122-33 |
| PubMed ID | 17182547 | Mgi Jnum | J:141945 |
| Mgi Id | MGI:3820051 | Doi | 10.4049/jimmunol.178.1.122 |
| Citation | Lovitch SB, et al. (2007) Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J Immunol 178(1):122-33 |
| abstractText | Type B T cells recognize a peptide-MHC conformer generated in recycling endosomes and eliminated by H2-DM in late endosomes; as a result, they recognize exogenous peptide, but fail to respond to the identical epitope generated from the native protein. To investigate the behavior of these cells in vivo, we generated mice transgenic for a type B TCR recognizing the 48-62 epitope of hen egg white lysozyme (HEL) presented by I-A(k). Type B T cells responded only to peptide ex vivo, but responded in vivo to immunization with either protein or peptide in the presence of Freund's adjuvant or LPS. Presentation of the type B conformer was MyD88-independent, evident within 24 h after HEL immunization, and restricted to the CD11b/c(+) APC subset. Immunization with listeriolysin O, a potent inducer of cell death, also primed type B T cells in vivo, and transfer of HEL-bearing allogeneic dendritic cells activated type B T cells. We conclude that a number of conditions in vivo, some of which induce inflammation and cell death, lead to peptide presentation through mechanisms distinct from the classical pathways involving H-2DM molecules. |
